About 70 percent of Americans with history of heart disease, stroke take aspirin
the ONA take:
About 70% of Americans who have heart disease or a stroke regularly take low-dose aspirin, according to a report from the U.S. Centers for Disease Control and Prevention (CDC).
For the study, researchers from the U.S. CDC analyzed data from the 2013 Behavioral Risk Factor Surveillance System, which included patients surveyed via telephone from 20 states and the District of Columbia. They found that 70.8% of respondents take low-dose aspirin regularly. More importantly, nearly 94% of those with a history of heart problems reported taking low-dose aspirin regularly to prevent a heart attack
In addition, approximately 80% reported taking it for stroke prevention and 76% said they take it to prevent both. Only 4% of respondents reporting taking low-dose aspirin for pain relief only.
Mississippi had the highest aspirin use with 72% of patients with heart problems regularly taking low-dose aspirin. Missouri had the lowest with 44%. Researchers found the males, people 65 years and older, whites, and patients with at least two cardiac risk factors are more likely to take aspirin compared with other groups.
The findings suggest that clinicians should target patients reporting lower regular aspirin use like Hispanics, blacks, and those who did not attain a high school diploma.
About 70% of Americans who have heart disease or a stroke regularly take low-dose aspirin.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Patients and Caregivers Worry About Cost of Cancer Care
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Seeking an Explanation for the Lack of Research Focused in Pediatric Oncology Therapeutics
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|